Synthesis Energy Systems, Inc. (NASDAQ:SYMX) shares moved down -1.14% in last trading session and ended the day at $0.96. SYMX Gross Margin is -27.10% and its has a return on assets of -52.70%. Synthesis Energy Systems, Inc. (NASDAQ:SYMX) quarterly performance is -18.81%.
Juniper Networks, Inc. (NYSE:JNPR) ended the last trading day at $31.49. Company weekly volatility is calculated as 2.49% and price to cash ratio as 6.55. Juniper Networks, Inc. (NYSE:JNPR) showed a weekly performance of 5.56%.
On 22 October, Juniper Networks Inc. (NYSE:JNPR) reported third-quarter earnings of $197.7 million. The Sunnyvale, California-based company said it had profit of 51 cents per share. Earnings, adjusted for one-time gains and costs, came to 57 cents per share. The results exceeded Wall Street expectations. The average estimate of 16 analysts surveyed by Zacks Investment Research was for earnings of 53 cents per share.
On 23 October, Western Gas Equity Partners, LP (NYSE:WGP) shares moved up 0.16% and was closed at $42.55. WGP EPS growth in last 5 year was 160.77%. Western Gas Equity Partners, LP (NYSE:WGP) year to date (YTD) performance is -28.13%.
Western Gas Equity Partners, LP (NYSE:WGP) announced that the board of directors of its general partner declared a quarterly cash distribution of $0.38125 per unit for the third quarter of 2015. This distribution represents a 5-percent increase over the prior quarter and a 31-percent increase over the third quarter of 2014. WGP’s third quarter 2015 distribution is payable on November 20, 2015, to unitholders of record at the close of business on November 2, 2015.
Merit Medical Systems, Inc. (NASDAQ:MMSI) shares moved down -25.68% in last trading session and ended the day at $17.91. MMSI Gross Margin is 44.20% and its has a return on assets of 3.90%. Merit Medical Systems, Inc. (NASDAQ:MMSI) quarterly performance is -28.87%.
On 22 October, Merit Medical Systems Inc. (NASDAQ:MMSI) reported third-quarter earnings of $4.8 million. On a per-share basis, the South Jordan, Utah-based company said it had net income of 11 cents. Earnings, adjusted for one-time gains and costs, were 20 cents per share. The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of 20 cents per share.
Kite Pharma, Inc. (NASDAQ:KITE) caters to the Healthcare space. Its weekly performance is 8.51%. On the last day of trading company shares ended up at $70.61. Kite Pharma, Inc. (NASDAQ:KITE) distance from 50-day simple moving average (SMA50) is 19.29%.
On 20 October, Kite Pharma, Inc. (NASDAQ:KITE), announced that the Company has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) for intellectual property related to T Cell Receptor (TCR)-based product candidates directed against MAGE A3 and A3/A6 antigens for the treatment of tumors expressing MAGE, which include lung, pancreatic, gastric, and breast cancers, among others.
Leave a Reply